{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T00:40:07Z","timestamp":1794789607379,"version":"4.9.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T00:00:00Z","timestamp":1689552000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T00:00:00Z","timestamp":1689552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100017823","name":"Center for AIDS Research, University of California Los Angeles","doi-asserted-by":"publisher","award":["AI028697"],"award-info":[{"award-number":["AI028697"]}],"id":[{"id":"10.13039\/100017823","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>There have been calls for \u201cperson-centered\u201d approaches to drug-resistant tuberculosis (DR-TB) care. In 2020, Charles James Hospital in South Africa, which incorporated person-centered care, was closed. Patients were referred mid-course to a centralized, tertiary hospital, providing an opportunity to examine person-centered DR-TB and HIV care from the perspective of patients who lost access to it.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The impact of transfer was explored through qualitative interviews performed using standard methods. Analysis involved grounded theory; interviews were assessed for theme and content.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>After switching to the centralized site, patients reported being unsatisfied with losing access to a single clinic and pharmacy where DR-TB, HIV and chronic disease care were integrated. Patients also reported a loss of care continuity; at the decentralized site there was a single, familiar clinician whereas the centralized site had multiple, changing clinicians and less satisfactory communication. Additionally, patients reported more disease-related stigma and less respectful treatment, noting the loss of a \u201cspecial place\u201d for DR-TB treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>By focusing on a DR-TB clinic closure, we uncovered aspects of person-centered care that were critical to people living with DR-TB and HIV. These perspectives can inform how care for DR-TB is operationalized to optimize treatment retention and effectiveness.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-023-08405-7","type":"journal-article","created":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T14:02:06Z","timestamp":1689602526000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["What clinic closure reveals about care for drug-resistant TB: a qualitative study"],"prefix":"10.1186","volume":"23","author":[{"given":"Thiloshini","family":"Govender","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer J.","family":"Furin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selvan","family":"Pillay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,17]]},"reference":[{"key":"8405_CR1","unstructured":"World Health Organization. Global Tuberculosis Report 2022. Accessed 26. May 2023 at: https:\/\/www.who.int\/teams\/global-tuberculosis-programme\/tb-reports."},{"key":"8405_CR2","doi-asserted-by":"publisher","first-page":"100101","DOI":"10.1016\/j.jctube.2019.100101","volume":"16","author":"Z Udwadia","year":"2019","unstructured":"Udwadia Z, Furin J. Quality of drug-resistant tuberculosis care: gaps and solutions. J Clin Tuberc Other Mycobact Dis. 2019;16:100101. https:\/\/doi.org\/10.1016\/j.jctube.2019.100101.","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"issue":"10","key":"8405_CR3","doi-asserted-by":"publisher","first-page":"784","DOI":"10.5588\/ijtld.21.0327","volume":"25","author":"S Horter","year":"2021","unstructured":"Horter S, Daftary A, Keam T, et al. Person-centred care in TB. Int J Tuberc Lung Dis. 2021;25(10):784\u20137. https:\/\/doi.org\/10.5588\/ijtld.21.0327.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"2","key":"8405_CR4","doi-asserted-by":"publisher","first-page":"133","DOI":"10.5588\/ijtld.17.0608","volume":"22","author":"A Odone","year":"2018","unstructured":"Odone A, Roberts B, Dara M, van den Boom M, Kluge H, McKee M. People- and patient-centred care for tuberculosis: models of care for tuberculosis. Int J Tuberc Lung Dis. 2018;22(2):133\u20138. https:\/\/doi.org\/10.5588\/ijtld.17.0608.","journal-title":"Int J Tuberc Lung Dis"},{"key":"8405_CR5","doi-asserted-by":"crossref","unstructured":"Govender T, Jham M, Zhang J. Decentralized, integrated treatment of RR\/MDR-TB and HIV using a bedaquiline-based, short regimen is effective and associated with improved HIV disease control. J Acquir Immune Defic Syndr (1988). Published online December 2022.","DOI":"10.1097\/QAI.0000000000003150"},{"issue":"2","key":"8405_CR6","doi-asserted-by":"publisher","first-page":"e57719","DOI":"10.1371\/journal.pone.0057719","volume":"8","author":"PC Chan","year":"2013","unstructured":"Chan PC, Huang SH, Yu MC, et al. Effectiveness of a government-organized and hospital-initiated treatment for multidrug-resistant tuberculosis patients\u2013a retrospective cohort study. PLoS ONE. 2013;8(2):e57719. https:\/\/doi.org\/10.1371\/journal.pone.0057719.","journal-title":"PLoS ONE"},{"issue":"1","key":"8405_CR7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ijtb.2018.04.011","volume":"66","author":"JB Mullerpattan","year":"2019","unstructured":"Mullerpattan JB, Udwadia ZZ, Banka RA, Ganatra SR, Udwadia ZF. Catastrophic costs of treating drug resistant TB patients in a tertiary care hospital in India. Indian J Tuberc. 2019;66(1):87\u201391. https:\/\/doi.org\/10.1016\/j.ijtb.2018.04.011.","journal-title":"Indian J Tuberc"},{"issue":"4","key":"8405_CR8","doi-asserted-by":"publisher","first-page":"441","DOI":"10.5588\/ijtld.13.0742","volume":"18","author":"H Cox","year":"2014","unstructured":"Cox H, Hughes J, Daniels J, et al. Community-based treatment of drug-resistant tuberculosis in Khayelitsha, South Africa. Int J Tuberc Lung Dis. 2014;18(4):441\u20138. https:\/\/doi.org\/10.5588\/ijtld.13.0742.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"2","key":"8405_CR9","doi-asserted-by":"publisher","first-page":"163","DOI":"10.5588\/ijtld.14.0369","volume":"19","author":"M Loveday","year":"2015","unstructured":"Loveday M, Wallengren K, Brust J, et al. Community-based care vs. centralised hospitalisation for MDR-TB patients, KwaZulu-Natal, South Africa. Int J Tuberc Lung Dis. 2015;19(2):163\u201371. https:\/\/doi.org\/10.5588\/ijtld.14.0369.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"8","key":"8405_CR10","doi-asserted-by":"publisher","first-page":"584","DOI":"10.2471\/BLT.17.193375","volume":"95","author":"J Ho","year":"2017","unstructured":"Ho J, Byrne AL, Linh NN, Jaramillo E, Fox GJ. Decentralized care for multidrug-resistant tuberculosis: a systematic review and meta-analysis. Bull World Health Organ. 2017;95(8):584\u201393. https:\/\/doi.org\/10.2471\/BLT.17.193375.","journal-title":"Bull World Health Organ"},{"issue":"3","key":"8405_CR11","doi-asserted-by":"publisher","first-page":"728","DOI":"10.3201\/eid2703.203204","volume":"27","author":"S Leavitt","year":"2021","unstructured":"Leavitt S, Jacobson KR, Ragan EJ, et al. Decentralized care for Rifampin-Resistant Tuberculosis, Western Cape, South Africa. Emerg Infect Dis. 2021;27(3):728\u201339. https:\/\/doi.org\/10.3201\/eid2703.203204.","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"8405_CR12","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.4102\/ajlm.v11i1.1811","volume":"11","author":"V Williams","year":"2022","unstructured":"Williams V, Calnan M, Edem B, et al. GeneXpert rollout in three high-burden tuberculosis countries in Africa: a review of pulmonary tuberculosis diagnosis and outcomes from 2001 to 2019. Afr J Lab Med. 2022;11(1):1811. https:\/\/doi.org\/10.4102\/ajlm.v11i1.1811.","journal-title":"Afr J Lab Med"},{"key":"8405_CR13","unstructured":"National TB Programme South Africa. Interim Clinical Guidance for the implementation of Injectable-free regimens for rifampicin-resistant tuberculosis in adults, Adolescents and Children."},{"key":"8405_CR14","doi-asserted-by":"crossref","unstructured":"Corbin J, Strauss A. Basics of qualitative research: techniques and procedures for developing grounded theory. Sage; 2008.","DOI":"10.4135\/9781452230153"},{"key":"8405_CR15","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1177\/146879410100100307","volume":"1","author":"J Attride-Stirling","year":"2001","unstructured":"Attride-Stirling J. Thematic networks: an analytic tool for qualitative research. Qual Res. 2001;1:385\u2013405.","journal-title":"Qual Res"},{"key":"8405_CR16","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208. https:\/\/doi.org\/10.1016\/j.jbi.2019.103208.","journal-title":"J Biomed Inform"},{"issue":"2","key":"8405_CR17","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381. https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010.","journal-title":"J Biomed Inform"},{"key":"8405_CR18","unstructured":"KwaZulu-Natal Department of Health Home Page. Accessed 26. May 2023: http:\/\/www.kznhealth.gov.za."},{"key":"8405_CR19","unstructured":"The World Bank Data Catalogue Home Page. Accessed 26. May 2023: https:\/\/datacatalog.worldbank.org\/search\/datase."},{"issue":"5","key":"8405_CR20","doi-asserted-by":"publisher","first-page":"e0232076","DOI":"10.1371\/journal.pone.0232076","volume":"15","author":"G Guest","year":"2020","unstructured":"Guest G, Namey E, Chen M. A simple method to assess and report thematic saturation in qualitative research. PLoS ONE. 2020;15(5):e0232076. https:\/\/doi.org\/10.1371\/journal.pone.0232076.","journal-title":"PLoS ONE"},{"issue":"1","key":"8405_CR21","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1186\/s13063-022-06331-8","volume":"23","author":"C Berry","year":"2022","unstructured":"Berry C, du Cros P, Fielding K, et al. TB-PRACTECAL: study protocol for a randomised, controlled, open-label, phase II-III trial to evaluate the safety and efficacy of regimens containing bedaquiline and pretomanid for the treatment of adult patients with pulmonary multidrug-resistant tuberculosis. Trials. 2022;23(1):484. https:\/\/doi.org\/10.1186\/s13063-022-06331-8.","journal-title":"Trials"},{"issue":"10","key":"8405_CR22","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.5588\/ijtld.20.0048","volume":"24","author":"N Padayatchi","year":"2020","unstructured":"Padayatchi N, Bionghi N, Osman F, et al. Treatment outcomes in patients with drug-resistant TB-HIV co-infection treated with bedaquiline and linezolid. Int J Tuberc Lung Dis. 2020;24(10):1024\u201331. https:\/\/doi.org\/10.5588\/ijtld.20.0048.","journal-title":"Int J Tuberc Lung Dis"},{"key":"8405_CR23","unstructured":"Brust JCM, Shah NS, Mlisana K, Moodley P, Allana S, Campbell A, Johnson BA, Master I, Mthiyane T, Lachman S, Larkan LM, Ning Y, Malik A, Smith JPGN. Improved survival and cure rates with concurrent treatment for MDR-TB\/HIV co-infection in South Africa. Clin Infect Dis. Published online 2017."},{"issue":"10248","key":"8405_CR24","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/S0140-6736(20)31316-7","volume":"396","author":"GP Bisson","year":"2020","unstructured":"Bisson GP, Bastos M, Campbell JR, et al. Mortality in adults with multidrug-resistant tuberculosis and HIV by antiretroviral therapy and tuberculosis drug use: an individual patient data meta-analysis. Lancet. 2020;396(10248):402\u201311. https:\/\/doi.org\/10.1016\/S0140-6736(20)31316-7.","journal-title":"Lancet"},{"issue":"9","key":"8405_CR25","doi-asserted-by":"publisher","first-page":"696","DOI":"10.5588\/ijtld.21.0125","volume":"25","author":"RA Murphy","year":"2021","unstructured":"Murphy RA, Douglas-Jones B, Mucinya G, Sunpath H, Govender T. Expanding the use of dolutegravir-based antiretroviral therapy in multidrug-resistant TB. Int J Tuberc Lung Dis. 2021;25(9):696\u2013700. https:\/\/doi.org\/10.5588\/ijtld.21.0125.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"9","key":"8405_CR26","doi-asserted-by":"publisher","first-page":"e3563","DOI":"10.1093\/cid\/ciaa1894","volume":"73","author":"I Tack","year":"2021","unstructured":"Tack I, Dumicho A, Ohler L, et al. Safety and Effectiveness of an All-Oral, Bedaquiline-Based, shorter treatment regimen for rifampicin-resistant tuberculosis in High Human Immunodeficiency Virus (HIV) Burden Rural South Africa: a retrospective cohort analysis. Clin Infect Dis. 2021;73(9):e3563\u201371. https:\/\/doi.org\/10.1093\/cid\/ciaa1894.","journal-title":"Clin Infect Dis"},{"key":"8405_CR27","unstructured":"Institute of Medicine. Envisioning the National Health Care Quality Report. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK223318\/; 2001."},{"issue":"4","key":"8405_CR28","doi-asserted-by":"publisher","first-page":"430","DOI":"10.5588\/ijtld.15.0360","volume":"20","author":"MR O\u2019Donnell","year":"2016","unstructured":"O\u2019Donnell MR, Daftary A, Frick M, et al. Re-inventing adherence: toward a patient-centered model of care for drug-resistant tuberculosis and HIV. Int J Tuberc Lung Dis. 2016;20(4):430\u20134. https:\/\/doi.org\/10.5588\/ijtld.15.0360.","journal-title":"Int J Tuberc Lung Dis"},{"key":"8405_CR29","unstructured":"A Policy Framework On Decentralized and Deinstitutionalized Management For South Africa. South Africa Department of Health. Accessed 26. May 2023: https:\/\/www.health.gov.za\/wp-content\/uploads\/2020\/11\/policy-framework-on-decentralised-management-of-mdr-tb-may-2019_compressed.pdf."},{"key":"8405_CR30","unstructured":"Massaut S. Patient Centered Approach Strategy.; 2008. Accessed 26 May 2023: https:\/\/www.challengetb.org\/publications\/tools\/ua\/TB_CARE_I_Patient_Centered_Approach.pdf."},{"issue":"1","key":"8405_CR31","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1186\/s12916-022-02624-6","volume":"20","author":"CF McQuaid","year":"2022","unstructured":"McQuaid CF, Henrion MYR, Burke RM, MacPherson P, Nzawa-Soko R, Horton KC. Inequalities in the impact of COVID-19-associated disruptions on tuberculosis diagnosis by age and sex in 45 high TB burden countries. BMC Med. 2022;20(1):432. https:\/\/doi.org\/10.1186\/s12916-022-02624-6.","journal-title":"BMC Med"},{"key":"8405_CR32","doi-asserted-by":"publisher","first-page":"1605225","DOI":"10.3389\/ijph.2022.1605225","volume":"67","author":"HV Masina","year":"2022","unstructured":"Masina HV, Lin IF, Chien LY. The impact of the COVID-19 pandemic on Tuberculosis Case Notification and Treatment Outcomes in Eswatini. Int J Public Health. 2022;67:1605225. https:\/\/doi.org\/10.3389\/ijph.2022.1605225.","journal-title":"Int J Public Health"},{"key":"8405_CR33","doi-asserted-by":"publisher","unstructured":"Manhi\u00e7a I, Augusto O, Sherr K, et al. COVID-19-related healthcare impacts: an uncontrolled, segmented time-series analysis of tuberculosis diagnosis services in Mozambique, 2017\u20132020. BMJ Glob Health. 2022;7(4). https:\/\/doi.org\/10.1136\/bmjgh-2021-007878.","DOI":"10.1136\/bmjgh-2021-007878"},{"issue":"8","key":"8405_CR34","doi-asserted-by":"publisher","first-page":"710","DOI":"10.5588\/ijtld.22.0006","volume":"26","author":"A Trajman","year":"2022","unstructured":"Trajman A, Felker I, Alves LC, et al. The COVID-19 and TB syndemic: the way forward. Int J Tuberc Lung Dis. 2022;26(8):710\u20139. https:\/\/doi.org\/10.5588\/ijtld.22.0006.","journal-title":"Int J Tuberc Lung Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08405-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-023-08405-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08405-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T14:02:30Z","timestamp":1689602550000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-023-08405-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,17]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["8405"],"URL":"https:\/\/doi.org\/10.1186\/s12879-023-08405-7","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,17]]},"assertion":[{"value":"29 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work was not previously reported at a conference or meeting.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conferences"}},{"value":"All authors declare no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Institutional Review Boards at the University of KwaZulu-Natal in Durban and at the University of California, Los Angeles and informed consent was obtained from each participant. All methods were carried out in accordance with relevant guidelines and regulations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. We carefully removed any details in the manuscript that could result in the identification of a specific participant.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"474"}}